```html

Huntington’s Disease: A Complete Medical Guide

Overview

Huntington’s disease (HD) is a progressive, inherited neurodegenerative disorder that causes uncontrolled movements, cognitive decline, and psychiatric symptoms. It results from an abnormal expansion of a CAG trinucleotide repeat in the HTT gene on chromosome 4, leading to the production of a toxic mutant huntingtin protein.

• Typical age of onset: 30–50 years, but symptoms can appear as early as childhood (juvenile HD) or as late as the 70s.
• Who it affects: Both men and women are equally susceptible; the disease follows an autosomal‑dominant inheritance pattern, meaning a child has a 50 % chance of inheriting the mutation from an affected parent.
• Prevalence: Approximately 5–10 per 100,000 people of European ancestry carry the gene, translating to about 30,000–40,000 individuals in the United States and roughly 6–10 per 100,000 worldwide. Prevalence is lower in Asian and African populations.<sup>CDC</sup>

Symptoms

Symptoms often appear gradually and become more severe over 10–20 years. They fall into three major categories: motor, cognitive, and psychiatric.

Motor Symptoms

• Chorea: Involuntary, writhing movements of the face, limbs, and trunk.
• Dystonia: Sustained muscle contractions causing abnormal postures.
• Impaired coordination (ataxia): Difficulties with gait, balance, and fine motor tasks.
• Rigidity & bradykinesia: Stiffness and slowed movements, similar to Parkinson’s disease.
• Swallowing difficulties (dysphagia): Can lead to weight loss and aspiration.
• Speech problems (dysarthria): Slurred or hoarse voice.

Cognitive Symptoms

• Executive dysfunction: Trouble planning, organizing, and multitasking.
• Memory impairment: Especially for recent events.
• Reduced insight: Patients may be unaware of their deficits.
• Slowed processing speed.

Psychiatric Symptoms

• Depression & anxiety: Occur in up to 60 % of patients.
• Irritability & aggression.
• Obsessive‑compulsive behaviors.
• Psychosis: Delusions or hallucinations in later stages.
• Suicidal thoughts: Higher risk; requires prompt evaluation.

Other Manifestations

• Weight loss despite normal intake (increased metabolic rate).
• Sleep disturbances, including insomnia and REM‑sleep behavior disorder.
• Autonomic dysfunction (e.g., urinary urgency).

Causes and Risk Factors

Genetic Cause

HD is caused by a mutation in the HTT gene. The normal allele contains 10–35 CAG repeats; ≥36 repeats cause disease, and larger repeat numbers generally lead to earlier onset and more rapid progression.

Inheritance Pattern

• Autosomal‑dominant: One mutated copy is enough to cause the disease.
• Each child of an affected parent has a 50 % chance of inheriting the mutant gene.

Risk Factors

• Family history: Presence of a parent or grandparent with HD.
• Large CAG repeat expansions: Inherited or de‑novo expansions increase risk of earlier onset (juvenile HD).
• Ethnicity: Higher carrier rates in people of European descent.

Non‑Genetic Influences

While the mutation is necessary for disease, environmental factors (e.g., head injury, substance use) may modestly affect age of onset, but data are limited.<sup>Mayo Clinic</sup>

Diagnosis

Diagnosing HD involves a combination of clinical evaluation, genetic testing, and sometimes neuroimaging.

Clinical Assessment

• Detailed neurological exam focusing on chorea, motor speed, and coordination.
• Neuropsychological testing to detect early cognitive changes.
• Psychiatric interview for mood and behavioral symptoms.

Genetic Testing

The definitive test is a PCR‑based assay that measures the number of CAG repeats in the HTT gene. Results are usually reported as:

• Normal: ≤ 35 repeats
• Intermediate (premutation): 36–39 repeats – may develop disease later or pass expanded repeats to offspring.
• Full mutation: ≥ 40 repeats – diagnostic for HD.

Genetic counseling before and after testing is essential because of the emotional and familial implications.

Neuroimaging (Supportive)

• MRI: Shows caudate nucleus atrophy and ventricular enlargement, correlating with disease severity.
• Functional imaging (PET, SPECT): Can demonstrate reduced dopamine uptake early in the course.

Differential Diagnosis

Conditions that can mimic HD include Wilson’s disease, Parkinson’s disease, chorea‑acanthocytosis, and certain medication‑induced movement disorders. A thorough work‑up helps exclude these.

Treatment Options

There is currently no cure for HD, but multiple therapies can alleviate symptoms and improve quality of life.

Pharmacologic Therapies

• Tetrabenazine (Xenazine) & Deutetrabenazine (Austedo): FDA‑approved for chorea; work by depleting dopamine.
• Antipsychotics (e.g., risperidone, olanzapine): Help control irritability, psychosis, and severe chorea.
• Antidepressants (SSRIs, SNRIs): Treat depression and anxiety.
• Mood stabilizers (e.g., valproic acid, carbamazepine): May reduce agitation.
• Amantadine: May modestly improve motor symptoms.
• Medication for sleep: Low‑dose trazodone or melatonin.

All medications should be started at low doses and titrated carefully, monitoring for side effects such as sedation, depression, or worsening motor function.

Procedural & Supportive Interventions

• Speech and language therapy: Improves articulation and swallowing.
• Physical and occupational therapy: Maintains mobility, balance, and daily living skills.
• Deep Brain Stimulation (DBS): Investigational for severe chorea; not yet standard of care.
• Nutrition support: High‑calorie diets, feeding tubes when dysphagia is severe.

Lifestyle & Home Measures

• Regular aerobic exercise (e.g., walking, cycling) 150 min/week to preserve motor function and mood.
• Balanced diet rich in protein, omega‑3 fatty acids, and antioxidants.
• Routine sleep schedule; limit caffeine and alcohol.
• Stress‑reduction techniques (mindfulness, yoga) for psychiatric symptoms.
• Use of adaptive equipment (grab bars, weighted utensils) to maintain independence.

Living with Huntington’s Disease

Care Planning

• Advance directives: Discuss wishes for future medical care while the patient can still participate.
• Legal & financial counseling: Power of attorney, guardianship, and insurance matters.
• Family education: Teach relatives about disease trajectory and safe caregiving techniques.

Support Resources

• Huntington’s Disease Society of America (HDSA) – support groups, webinars, and caregiving toolkits.
• National Institutes of Health (NIH) Clinical Trials – opportunities to enroll in experimental therapies.
• Online communities (e.g., PatientsLikeMe, Reddit r/Huntingtons).

Practical Daily Tips

1. Structure the day: Regular meals, medication times, and activity blocks reduce confusion.
2. Safety proof the home: Remove tripping hazards, install night lights, and consider a medical alert system.
3. Monitor weight: Record weekly; involve a dietitian if loss >5 % of body weight.
4. Encourage social interaction: Even brief visits can improve mood and cognition.
5. Document changes: Use a symptom diary to communicate effectively with healthcare providers.

Prevention

Because HD is a genetic disorder, primary prevention (avoiding the disease) is not possible. However, the following steps can reduce the impact on families and future generations:

• Genetic counseling: Before family planning, discuss carrier testing and reproductive options (pre‑implantation genetic diagnosis, prenatal testing).
• Reproductive choices: In vitro fertilization with embryos screened for the HTT mutation can prevent transmission.
• Educate at‑risk relatives: Early testing allows for timely monitoring and lifestyle modifications.

Complications

If left untreated or inadequately managed, HD can lead to serious complications that shorten life expectancy (average 15–20 years after symptom onset).

• Pneumonia: Aspiration from dysphagia is the leading cause of death.
• Falls & fractures: Due to balance and gait problems.
• Severe depression & suicide: Requires vigilant mental‑health follow‑up.
• Malnutrition & dehydration: From swallowing difficulties and increased metabolic rate.
• Urinary infections: Resulting from incomplete bladder emptying.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institutes of Health, Huntington’s Disease Society of America, Cleveland Clinic, World Health Organization, peer‑reviewed journals (e.g., Neurology, Movement Disorders).

```